Computational Image Analysis of Nuclear Morphology Distinguishes Ductal Carcinoma In Situ from Usual Ductal Hyperplasia of the Breast

被引：0
|
作者：
Dong, F.
Lerwill, M. F.
Brachtel, E. F.
Knoblauch, N. W.
Montaser-Kouhsari, L.
Jones, N. C.
Wilbur, D. C.
Beck, A. H.
机构：
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
[3] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
来源：
LABORATORY INVESTIGATION | 2014年 / 94卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
175
引用
收藏
页码：45A / 46A
页数：2
相关论文
共 50 条
  • [11] Estrogen Receptor and Cytokeratin 5 Are Reliable Markers to Separate Usual Ductal Hyperplasia From Atypical Ductal Hyperplasia and Low-Grade Ductal Carcinoma In Situ
    Martinez, Anthony P.
    Cohen, Cynthia
    Hanley, Krisztina Z.
    Li, Xiaoxian
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2016, 140 (07) : 686 - 689
  • [12] Breast ductal carcinoma in situ: nuclear grading by discriminant analysis of image features.
    Axelrod, DE
    Chapman, JW
    Miller, NA
    Christens-Barry, WA
    Lickley, HLA
    Fu, Y
    Hanna, WM
    Rutgers, WM
    BREAST CANCER RESEARCH AND TREATMENT, 2002, 76 : S70 - S70
  • [13] Quantitative nuclear morphometry by image analysis for prediction of recurrence of ductal carcinoma in situ of the breast
    Hoque, A
    Lippman, SM
    Boiko, IV
    Atkinson, EN
    Sneige, N
    Sahin, A
    Weber, DM
    Risin, S
    Lagios, MD
    Schwarting, P
    Colburn, WJ
    Dhingra, K
    Follen, M
    Kelloff, GJ
    Boone, CW
    Hittelman, WN
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2001, 10 (03) : 249 - 259
  • [14] Prospective Analysis Using a Novel CNN Algorithm to Distinguish Atypical Ductal Hyperplasia From Ductal Carcinoma in Situ in Breast
    Mutasa, Simukayi
    Chang, Peter
    Nemer, John
    Van Sant, Eduardo Pascual
    Sun, Mary
    McIlvride, Alison
    Siddique, Maham
    Ha, Richard
    CLINICAL BREAST CANCER, 2020, 20 (06) : E757 - E760
  • [15] Cytological criteria for the diagnosis of intraductal hyperplasia, ductal carcinoma in situ, and invasive ductal carcinoma of the breast
    Bofin, AM
    Fjosne, HE
    Hagmar, BM
    JOURNAL OF PATHOLOGY, 2002, 198 : 29A - 29A
  • [16] Thymidine kinase 1 expression in atypical ductal hyperplasia significantly differs from usual ductal hyperplasia and ductal carcinoma in situ: A useful tool in tumor therapy management
    Guan, Hong
    Sun, Yanhua
    Zan, Qin
    Xu, Meiquan
    Li, Yuan
    Zhou, Ji
    He, Ellen
    Eriksson, Staffan
    Wen, Wen
    Skog, Sven
    MOLECULAR MEDICINE REPORTS, 2009, 2 (06) : 923 - 929
  • [17] CXCR4 is expressed in ductal carcinoma in situ of the breast and in atypical ductal hyperplasia
    Schmid, BC
    Rudas, M
    Rezniczek, GA
    Leodolter, S
    Zeillinger, R
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 84 (03) : 247 - 250
  • [18] CXCR4 is Expressed in Ductal Carcinoma in situ of the Breast and in Atypical Ductal Hyperplasia
    Bernd C. Schmid
    Margarethe Rudas
    Günther A. Rezniczek
    Sepp Leodolter
    Robert Zeillinger
    Breast Cancer Research and Treatment, 2004, 84 : 247 - 250
  • [19] TP53 alterations in atypical ductal hyperplasia and ductal carcinoma in situ of the breast
    Chitemerere, M
    Andersen, TI
    Holm, R
    Karlsen, F
    Borresen, AL
    Nesland, JM
    BREAST CANCER RESEARCH AND TREATMENT, 1996, 41 (02) : 103 - 109
  • [20] Solid papillary ductal carcinoma in situ versus usual ductal hyperplasia in the breast: a potentially difficult distinction resolved by cytokeratin 5/6
    Rabban, Joseph T.
    Koerner, Frederick C.
    Lerwill, Melinda F.
    HUMAN PATHOLOGY, 2006, 37 (07) : 787 - 793
12345